This inventor holds 1 USPTO granted patent. Top assignee: Research Development Corporation of Japan. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Chise Tateno: Innovator in Hepatic Cell Research
Introduction
Chise Tateno is a prominent inventor based in Hiroshima, Japan. She has made significant contributions to the field of hepatic cell research, particularly through her innovative patent related to liver parenchymal cells. Her work aims to enhance the understanding of liver cell development and differentiation, which is crucial for advancing therapeutic methods for liver diseases.
Latest Patents
Chise Tateno holds a patent for "Liver parenchymal cells having clonal growth ability, method for." This invention provides liver parenchymal cells that possess clonal growth ability and various cell biological properties. These properties include the presence of peroxisomes, positivity to hepatocyte markers, and partial positivity to neoplastic hepatocyte markers. The invention also outlines methods for obtaining and subculturing these cells, which can facilitate detailed research into liver cell growth mechanisms and the development of therapeutic methods for liver diseases.
Career Highlights
Chise Tateno is associated with the Research Development Corporation of Japan, where she continues to explore innovative solutions in the field of liver research. Her dedication to advancing scientific knowledge has positioned her as a key figure in her area of expertise.
Collaborations
Chise Tateno collaborates with Katsutoshi Yoshizato, contributing to the advancement of research in hepatic cells. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Chise Tateno's work in hepatic cell research represents a significant advancement in understanding liver biology and disease. Her innovative patent and ongoing research efforts are paving the way for new therapeutic approaches to liver-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile